Feedback
The current prices are delayed. Login to see live prices.

Syngene International Ltd.

(SYNGENE)

701234567892012345678960123456789.2012345678900123456789
+6.65 (+0.92%)
Updated 15:56 28/03 IST
Add
Previous Close: 719.55
Today's low
₹716.30
Today's high
₹731.8
52 week low
₹607.65
52 week high
₹960.6
Open
₹724
Prev Close
₹719.55
Volume (shares)
547,825
Total Trading Value
39.42 Cr

Technicals

SMA
Value
Signal
12-SMA
695.97
Bullish
20-SMA
713.13
Bullish
50-SMA
783.57
Bearish
100-SMA
832.03
Bearish
200-SMA
809.05
Bearish

Discussions

  •  Yesterday 8:17 PM
Technical analysis...read more

8

  •  Feb 24 4:17 PM
  •  Feb 8 3:06 AM
SYNGENE
TIME FRAME DAILY ...read more

3

2
  •  Feb 20 8:23 PM
#SYNGENE Daily ichimoku. Cross above and sustain, conversion line/ tks. ...

2

2

  •  Jan 22 2:11 PM
Pre Open Recommendations
👉...read more

1

  •  Dec 12, 2024 1:58 PM
Syngene International Ltd view for Intraday 12th Dec #SYNGENE
Resistance 910 Watching above 912 for upside movement......read more

4

  •  Jan 21 2:23 PM
Pre Open Recommendations
👉...read more

1

1
  •  Feb 17 1:22 PM
INTRADAY TRADING ...read more

3

Load More Posts

Frequently Asked Questions (FAQs)

What is the Share Price of Syngene International Ltd. ?

The share prices are volatile and fluctuate throughout the trading hours. The share price of Syngene International Ltd. is Rs 719.55 as of 28 March 2025.

What is the Market Capitalization of Syngene International Ltd. ?

The current market cap of Syngene International Ltd. is undefined Market capitalisation is calculated by multiplying the current share price with the total number of shares.

What are the PE and PB ratios of Syngene International Ltd.?

Syngene International Ltd. has a price-to-earnings (PE) ratio of undefined and a price-to-book (PB) ratio of undefined.

What is the 52-week high/low of Syngene International Ltd.?

The 52-week high of Syngene International Ltd. is Rs 960.6 and the 52-week low is Rs 607.65
Hero Img
Join 10,00,000 Indian traders and discuss trades, strategies, news & views on any stock.
Create your account on Frontpage
DisclaimerPrivacy
FrontPage © 2025